Article info
Aetiology
Commentary
Randomised controlled trial: extended-duration dabigatran is non-inferior to warfarin and more effective than placebo for symptomatic VTE
- Correspondence to : Dr Timothy K Liem, Division of Vascular Surgery OP-11, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA; liemt{at}ohsu.edu
Citation
Randomised controlled trial: extended-duration dabigatran is non-inferior to warfarin and more effective than placebo for symptomatic VTE
Publication history
- First published June 8, 2013.
Online issue publication
January 22, 2014
Article Versions
- Previous version (8 June 2013).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions